One of the consequences of the JAK2V617F mutation in haematopoietic progenitors is the increased production of TGF‐β in the bone marrow microenvironment, which is associated with the secondary development of myelofibrosis.10 This evidence concerns the gene TGFB1 and myelofibrosis.